Literature DB >> 28556093

Recovery of rat muscle size but not function more than 1 year after a single botulinum toxin injection.

Samuel R Ward1,2,3, Viviane B Minamoto1, Kentaro P Suzuki1, Jonah B Hulst1, Shannon N Bremner1, Richard L Lieber1,2,4.   

Abstract

INTRODUCTION: Neurotoxin injection is used to treat a wide variety of neuromuscular disorders. The purpose of this study was to measure the functional and structural properties of botulinum toxin-injected adult rat skeletal muscle over nearly the entire lifespan.
METHODS: Ten groups of animals were subjected to either neurotoxin injection [Botox, Type A (BT-A); Allergan, Irvine, California] or saline solution injection. Neurotoxin-injected animals (n = 90) were analyzed at different time-points: 1 week; 1 month; 3 months; 6 months; 12 months; or 18 months.
RESULTS: In spite of the recovery of structural features, such as muscle mass and fiber area, dorsiflexion torque production remained significantly depressed by 25%, even at 12 months after neurotoxin injection. DISCUSSION: The data demonstrate that, after a single BT-A injection, although gross muscle morphology recovered over a 12-month time period, loss of contractile function did not recover. Muscle Nerve 57: 435-441, 2018.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Botox; aging; denervation neurotoxin; muscle fiber type; muscle physiology; neuromuscular junction

Mesh:

Substances:

Year:  2017        PMID: 28556093      PMCID: PMC5702600          DOI: 10.1002/mus.25707

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  32 in total

1.  Spasticity causes a fundamental rearrangement of muscle-joint interaction.

Authors:  Richard L Lieber; Jan Fridén
Journal:  Muscle Nerve       Date:  2002-02       Impact factor: 3.217

2.  Asynchronous functional, cellular and transcriptional changes after a bout of eccentric exercise in the rat.

Authors:  David Peters; Ilona A Barash; Michael Burdi; Philip S Yuan; Liby Mathew; Jan Fridén; Richard L Lieber
Journal:  J Physiol       Date:  2003-09-26       Impact factor: 5.182

3.  Spastic muscle cells are shorter and stiffer than normal cells.

Authors:  Jan Fridén; Richard L Lieber
Journal:  Muscle Nerve       Date:  2003-02       Impact factor: 3.217

4.  Changes in contractile properties of muscles receiving repeat injections of botulinum toxin (Botox).

Authors:  Rafael Fortuna; Marco Aurélio Vaz; Aliaa Rehan Youssef; David Longino; Walter Herzog
Journal:  J Biomech       Date:  2010-09-15       Impact factor: 2.712

5.  Fatal case of BOTOX-related anaphylaxis?

Authors:  Melissa Li; Bruce A Goldberger; Carolyn Hopkins
Journal:  J Forensic Sci       Date:  2005-01       Impact factor: 1.832

6.  Hamstring contractures in children with spastic cerebral palsy result from a stiffer extracellular matrix and increased in vivo sarcomere length.

Authors:  Lucas R Smith; Ki S Lee; Samuel R Ward; Henry G Chambers; Richard L Lieber
Journal:  J Physiol       Date:  2011-03-21       Impact factor: 5.182

7.  Long-term effects of spinal cord transection on fast and slow rat skeletal muscle. I. Contractile properties.

Authors:  R L Lieber; C B Johansson; H L Vahlsing; A R Hargens; E R Feringa
Journal:  Exp Neurol       Date:  1986-03       Impact factor: 5.330

8.  Botulinum toxin: mechanism of presynaptic blockade.

Authors:  I Kao; D B Drachman; D L Price
Journal:  Science       Date:  1976-09-24       Impact factor: 47.728

Review 9.  Botulinum toxin: dosing and dilution.

Authors:  Gerard E Francisco
Journal:  Am J Phys Med Rehabil       Date:  2004-10       Impact factor: 2.159

Review 10.  Systems analysis of biological networks in skeletal muscle function.

Authors:  Lucas R Smith; Gretchen Meyer; Richard L Lieber
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2012-11-27
View more
  7 in total

1.  Adverse Events Associated With Botox as Reported in a Food and Drug Administration Database.

Authors:  Salma Ahsanuddin; Savannah Roy; Wissam Nasser; Roman Povolotskiy; Boris Paskhover
Journal:  Aesthetic Plast Surg       Date:  2020-10-30       Impact factor: 2.326

Review 2.  Over 25 Years of Pediatric Botulinum Toxin Treatments: What Have We Learned from Injection Techniques, Doses, Dilutions, and Recovery of Repeated Injections?

Authors:  Heli Sätilä
Journal:  Toxins (Basel)       Date:  2020-07-06       Impact factor: 4.546

3.  Characteristic Variation of Electromechanical Delay After the Botulinum Toxin Injection in Spastic Biceps Brachii Muscles.

Authors:  Sourav Chandra; Babak Afsharipour; William Z Rymer; Nina L Suresh
Journal:  Front Neurol       Date:  2022-02-10       Impact factor: 4.003

4.  Recombinant botulinum neurotoxin serotype A1 in vivo characterization.

Authors:  Cindy Périer; Vincent Martin; Sylvie Cornet; Christine Favre-Guilmard; Marie-Noelle Rocher; Julien Bindler; Stéphanie Wagner; Emile Andriambeloson; Brian Rudkin; Rudy Marty; Alban Vignaud; Matthew Beard; Stephane Lezmi; Mikhail Kalinichev
Journal:  Pharmacol Res Perspect       Date:  2021-10

5.  Comprehensive Assessment of the Time Course of Biomechanical, Electrophysiological and Neuro-Motor Effects after Botulinum Toxin Injections in Elbow Flexors of Chronic Stroke Survivors with Spastic Hemiplegia: A Cross Sectional Observation Study.

Authors:  Yen-Ting Chen; Yang Liu; Chuan Zhang; Elaine Magat; Ping Zhou; Yingchun Zhang; Sheng Li
Journal:  Toxins (Basel)       Date:  2022-01-28       Impact factor: 4.546

6.  Reduced Cross-Sectional Muscle Growth Six Months after Botulinum Toxin Type-A Injection in Children with Spastic Cerebral Palsy.

Authors:  Nathalie De Beukelaer; Guido Weide; Ester Huyghe; Ines Vandekerckhove; Britta Hanssen; Nicky Peeters; Julie Uytterhoeven; Jorieke Deschrevel; Karen Maes; Marlies Corvelyn; Domiziana Costamagna; Ghislaine Gayan-Ramirez; Anja Van Campenhout; Kaat Desloovere
Journal:  Toxins (Basel)       Date:  2022-02-14       Impact factor: 4.546

Review 7.  Management of pain in patients with temporomandibular disorder (TMD): challenges and solutions.

Authors:  Alfonso Gil-Martínez; Alba Paris-Alemany; Ibai López-de-Uralde-Villanueva; Roy La Touche
Journal:  J Pain Res       Date:  2018-03-16       Impact factor: 3.133

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.